J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mowat, E.
Right arrow Articles by Ramage, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mowat, E.
Right arrow Articles by Ramage, G.
Agricola
Right arrow Articles by Mowat, E.
Right arrow Articles by Ramage, G.
J Med Microbiol 56 (2007), 1205-1212; DOI: 10.1099/jmm.0.47247-0
© 2007 Society for General Microbiology
ISSN 1473-5644

Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus

Eilidh Mowat1, John Butcher1, Sue Lang1, Craig Williams2 and Gordon Ramage3

1 Department of Biological and Biomedical Sciences, Glasgow Caledonian University, Glasgow, UK

2 Microbiology Department, Yorkhill Hospital, Glasgow, UK

3 Section of Infection and Immunity, Glasgow University Dental School and Hospital, Glasgow, UK

Correspondence
Gordon Ramage
g.ramage{at}dental.gla.ac.uk

Received 21 February 2007
Accepted 14 May 2007

Aspergillus fumigatus is an increasingly prevalent opportunistic fungal pathogen of various immunocompromised individuals. It has the ability to form filaments within the lungs, producing dense intertwined mycelial balls, which are difficult to treat. The aim of this study was to develop a suitable model of A. fumigatus to examine the effects of antifungal challenge on these intertwined filamentous communities. A. fumigatus NCPF 7367 growth conditions were optimized on both Thermanox coverslips and on flat-bottomed microtitre plates to establish optimal conidial seeding densities. Isolates were treated with itraconazole, voriconazole, amphotericin B and caspofungin and their overall killing efficiency was measured using an XTT formazan metabolic dye assay. This was compared with the CLSI (formerly NCCLS) methodology of broth microdilution of moulds (standard M38-A). It was shown that 1x105 conidia ml–1 in RPMI 1640 was the optimum concentration of spores for biofilm formation. Filamentous growth characteristics were not observed until 10 h incubation, followed by an exponential increase in the biofilm biomass (hyphae and extracellular material) and cellular activity (metabolism). When susceptibility testing of biofilms was compared with that of planktonic cells by CLSI broth microdilution testing, all antifungal drugs were at least 1000 times less effective at reducing the overall metabolic activity of 90 % of the cells. Overall, this study showed that A. fumigatus has the ability to form coherent multicellular biofilm structures that are resistant to the effects of antifungal drugs.

Abbreviations: ABPA allergic bronchopulmonary aspergillosis; AmpB, amphotericin B; CF, cystic fibrosis; CLSM, confocal laser scanning microscopy; IA, invasive aspergillosis; PMIC, planktonic cell MIC; SMIC, sessile cell MIC; XTT, 2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide.




This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
J. Chen, X. Song, P. Yang, and J. Wang
Appearance of Anaphylactic Shock after Long-Term Intravenous Itraconazole Treatment
Ann. Pharmacother., March 1, 2009; 43(3): 537 - 541.
[Abstract] [Full Text] [PDF]

Home page
 Eukaryot CellHome page
M. T. Cushion, M. S. Collins, and M. J. Linke
Biofilm Formation by Pneumocystis spp.
Eukaryot. Cell, February 1, 2009; 8(2): 197 - 206.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
E. Mowat, S. Lang, C. Williams, E. McCulloch, B. Jones, and G. Ramage
Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms
J. Antimicrob. Chemother., December 1, 2008; 62(6): 1281 - 1284.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. J. Seidler, S. Salvenmoser, and F.-M. C. Muller
Aspergillus fumigatus Forms Biofilms with Reduced Antifungal Drug Susceptibility on Bronchial Epithelial Cells
Antimicrob. Agents Chemother., November 1, 2008; 52(11): 4130 - 4136.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
A. S. Shehata, P. K. Mukherjee, and M. A. Ghannoum
Comparison between the Standardized Clinical and Laboratory Standards Institute M38-A2 Method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2H-Tetrazolium Hydroxide- Based Method for Testing Antifungal Susceptibility of Dermatophytes
J. Clin. Microbiol., November 1, 2008; 46(11): 3668 - 3671.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
K. Smith, A. Perez, G. Ramage, D. Lappin, C. G. Gemmell, and S. Lang
Biofilm formation by Scottish clinical isolates of Staphylococcus aureus
J. Med. Microbiol., August 1, 2008; 57(8): 1018 - 1023.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2007 Society for General Microbiology.